- Use of dopamine agonists in Parkinson's disease2014 | Publication without faculty affiliation
- Dopamine agonist-induced generalized edema in Parkinson's disease2009 | First Faculty of Medicine
- Valvular heart disease in relation to the treatment of hyperprolactinemia with dopamine agonists2017 | Faculty of Medicine in Hradec Králové
- Brexpiprazole: a profile of new antipsychotic from the partial dopamine agonist class2020 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Reply: Heart valve abnormalities in Parkinson's disease treated with dopamine agonists2008 | First Faculty of Medicine, Third Faculty of Medicine
- Dopamine agonists in tumor cell recognitionPublication without faculty affiliation
- Dopamine agonists and valvular heart disease2007 | First Faculty of Medicine
- Dopamine agonists treatment in Parkinson's disease: experience with Pergolide2000 | First Faculty of Medicine
- Initiation of therapy and utilization of dopamine agonists in early period of Parkinson's disease2004 | First Faculty of Medicine
- Cognitive performance in people with Parkinson?s disease and mild or moderfate depression: effects of dopamine agonists in an add-on to L-dopa therapy2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Structural study of dopamine agonist lisuride2003 | Faculty of Science
- Dopamine agonists and valvular heart disease2007 | First Faculty of Medicine, Third Faculty of Medicine
- Structural study of dopamine agonist lisuride2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Prolactinoma resistant to treatment with dopamine agonists2022 | Faculty of Medicine in Hradec Králové
- Sleep disorders and excessive daytime sleepiness in Parkinson's disease: L-DOPA and dopamine agonists are equally implicatedPublication without faculty affiliation
- Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal2019 | First Faculty of Medicine
- Hyperprolactinemia and prolactinomas2017 | First Faculty of Medicine
- Diagnosis and treatment of prolactinomas2009 | First Faculty of Medicine
- Cabergoline in prevention and treatment of ovarian hyperstimulation syndrome2023 | First Faculty of Medicine
- Organ changes in duced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease2005 | First Faculty of Medicine
- Cognitive performance in people with Parkinson’s disease and mild or moderfate depression: effects of dopamine agonists in an add-on to L-dopa therapy2005 | Faculty of Medicine in Pilsen
- Restless legs syndrome- the state of the art in treatment2007 | First Faculty of Medicine
- Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide2007 | Third Faculty of Medicine
- Impulse control disorders in patients with young-onset Parkinson's disease: A cross-sectional study seeking associated factors2016 | First Faculty of Medicine
- Brexpiprazole +12019 | Publication without faculty affiliation
- Use of the Leksell gamma knife in the treatment of prolactinoma patients2009 | First Faculty of Medicine
- Clinically non-functioning pituitary adenomas - possibilities of medical treatment +12009 | Faculty of Medicine in Hradec Králové
- Clinically non-functioning pituitary adenomas - possibilities of medical treatment2009 | First Faculty of Medicine